Long-lasting effects of chronic μ-opioid intake on the signal transmission via dopamine D1 receptors in the limbic forebrain of drug deprived rats

Neuropharmacology

Volumn 37, Issue 8, 1998, Pages 997-1006

  May, Torsten ^a   Juilfs, Folkert ^a   Wolffgramm, Jochen ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Abstinence; Adenylyl cyclase; Dopamine D1 receptor; Opioid; Oral self administration; Withdrawal

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIHYDREXIDINE; DOPAMINE; DOPAMINE 1 RECEPTOR; ETONITAZENE; FORSKOLIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KETANSERIN; OPIATE;

ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; FOREBRAIN; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADMINISTRATION, ORAL; ANIMALS; BENZIMIDAZOLES; ENZYME INHIBITORS; FORSKOLIN; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANYLYL IMIDODIPHOSPHATE; MALE; NARCOTICS; NUCLEUS ACCUMBENS; OLFACTORY BULB; PHENANTHRIDINES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, OPIOID, MU; SELF ADMINISTRATION; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 0031716801     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00089-6     Document Type: Article

References (36)

1. Bonci, A., Williams, J.T., 1996. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16, 631-639.
2. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
3. Christie, McD.J., Williams, J.T., Osborne, P.B., Bellchambers, C.E., 1997. Where is the locus in opioid withdrawal? Trends Pharmacol. Sci. 18, 134-140.
4. Chuang, T.T., Iacovelli, L., Sallese, M., De Blasi, A., 1996. G protein-coupled receptors: Heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci. 17, 416-421.
5. Dhawan, B.N., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P.B., Portoghese, P.S., Hamon, M., 1996. International union of pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev. 48, 567-592.
6. Di Chiara, G., Imperato, A., 1988. Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85, 5274-5278.
7. Di Chiara, G., North, R.A., 1992. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13, 185-192.
8. 1 agonists in human caudate: biochemical properties and therapeutic implications. Neuropharmacology 34, 481-488.
9. Glowinski, J., Iverson, L.L., 1966. Regional studies of the catecholamines in the rat brain-I. The disposition of the [H]norepinephrine, [H]dopamine and [H]dopa in various regions of the rat brain. J. Neurochem. 13, 655-669.
10. Gudermann, T., Kalkbrenner, F., Schultz, G., 1996. Diversity and selectivity of receptor-G protein interaction. Ann. Rev. Pharmacol. Toxicol. 36, 429-459.
11. 2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371, 155-157.
12. Herz, A., 1995. Opposing tonically active endogenous opioid system modulating the mesolimbic dopamine reward pathway. In: Tagliamonte, A., Maremmani, I. (Eds.), Drug Addiction and Related Clinical Problems. Springer Verlag, Wien, pp. 1-11.
13. Heyne, A., 1996. The development of opiate addiction in the rat. Pharmacol. Biochem. Behav. 53, 11-25.
14. Hyyatiä, P., Sinclair, J.D., 1993. Oral etonitazene and cocaine consumption by AA, ANA and Wistar rats. Psychopharmacology 111, 409-414.
15. Jaber, M., Robinson, S.W., Missale, C., Caron, M.G., 1996. Dopamine receptors and brain function. Neuropharmacology 35, 1503-1519.
16. Koob, G.F., Le Moal, M., 1997. Drug abuse: hedonic homeostatic dysregulation. Science 278, 52-58.
17. 1-like receptors have higher affinity for dopamine in ethanol-treated rats. Eur. J. Pharmacol. 215, 313-316.
18. May, T., Sugawa, M., 1993. Altered dopamine receptor mediated signal transmission in the striatum of aged rats. Brain Res. 604, 106-111.
19. May, T., Wolf, U., Wolffgramm, J., 1995. Striatal dopamine receptors and adenylyl cyclase activity in a rat model of alcohol addiction: effects of ethanol and lisuride treatment. J. Pharmacol. Exp. Ther. 275, 1195-1203.
20. Nestler, E.J., Aghajanian, K., 1997. Molecular and cellular basis of addiction. Science 278, 58-63.
21. 1 receptors depends on intrinsic activity. Neuropharmacology 31, 177-183.
22. Pollock, J., Kornetsky, C., 1996. Reexpression of morphine-induced oral stereotypy 6 months after last morphine sensitizing dose. Pharmacol. Biochem. Behav. 53, 67-71.
23. Robinson, T.E., Berridge, K.C., 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291.
24. Sala, M., Braida, D., Calcaterra, P., Leone, M.P., Gori, E., 1992. Dose-dependent conditioned place preference produced by etonitazene and morphine. Eur. J. Pharmacol. 217, 37-41.
25. Scatchard, G., 1949. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51, 660-672.
26. Schultz, G., Jakobs, K.H., 1985. Adenylate cyclase. In: Bergmeyer, H.U. (Ed.), Methods of Enzymatic Analysis. Verlag Chemie, Weinheim, pp. 369-378.
27. Sklair-Tavron, L., Shi, W.-X., Lane, S.B., Harris, H.W., Bunney, B.S., Nestler, E.J., 1996. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. USA 93, 11202-11207.
28. Spanagel, R., 1995. Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav. Brain Res. 70, 37-49.
29. Sunahara, R.K., Dessauer, C.W., Gilman, A.G., 1996. Complexity and diversity of mammalian adenylyl cyclases. Ann. Rev. Pharmacol. Toxicol. 36, 461-480.
30. Swillens, S., Waelbroeck, M., Champeil, P., 1995. Does a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites? Trends Pharmacol. Sci. 16, 151-155.
31. 1A receptor responsiveness by various G protein-coupled receptor kinases. J. Biol. Chem. 271, 3771-3778.
32. Vanderschuren, L.J.M.J., Tjon, G.H.K., Nestby, P., Mulder, A.H., Schoffelmeer, A.N.M., De Vries, T.J., 1997. Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of the pretreatment regimen. Psychopharmacology 131, 115-122.
33. 1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol. Pharmacol. 48, 988-994.
34. Wikler, A., Martin, W.R., Pescor, F.T., Eades, C.G., 1963. Factors regulating oral consumption of an opioid (etonitazene) by morphine-addicted rats. Psychopharmacologia 5, 55-76.
35. Wolffgramm, J., Heyne, A., 1995. From controlled drug intake to loss of control: the irreversible development of drug addiction in the rat. Behav. Brain Res. 70, 77-94.
36. Zernig, G., Issaevitch, T., Broadbear, J.H., Burke, T.F., Lewis, J.W., Brine, G.A., Woods, J.H., 1995. Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding. Life Sci. 57, 2113-2125.